Table 1 Patients’ clinical and laboratory pre-ECMO characteristics of the study population

Age (years)

62 ± 13

61 ± 12

0.564

Gender (male (%))

68 (64.2%)

33 (70.2%)

0.465

BSA (m²)

2 ± 0.2

1.9 ± 0.2

0.730

Indexed DO₂ (L/min/m²)

267.4 ± 69

297.1 ± 60.9

0.057

ECMO indication

 Arrhythmia

1 (0.9%)

3 (6.4%)

0.019

 Postcardiotomy heart failure

54 (50.9%)

29 (61.7%)

 Cardiogenic shock

30 (28.3%)

10 (21.3%)

 ECPR

17 (16.1%)

1 (2.1%)

 Others*

4 (3.8%)

4 (8.5%)

Decision to initiate ECMO within 8 h of onset of failure (Yes (%))

81 (76.4%)

46 (97.9%)

0.001

Cannulation

 Femoro-femoral

92 (86.8%)

36 (76.6%)

0.253

 Femoral-aortic

13 (12.3%)

9 (19.1%)

 Atrio-aortic

1 (0.9%)

1 (2.1%)

 Femoral-pulmonary artery

0 (0%)

1 (2.1%)

ECMO duration (hours)

79.4 ± 93.4

150 ± 137.9

 < 0.001

IABP (yes (%))

29 (27.4%)

16 (34%)

0.403

CVVH (yes (%))

44 (41.5%)

12 (25.5%)

0.058